Loading content…
Affiliate-supportedIndependent editorialWe never sell medicationSee how
South · Tennessee
Local context for Wegovy, Ozempic, Mounjaro, and Zepbound in Nashville (690,000 residents, 2,050,000 metro). TennCare (TN Medicaid) covers T2D GLP-1s with prior auth, though Tennessee has not adopted full ACA expansion; Vanderbilt anchors academic care.
Availability and prices vary by pharmacy and date. We do not maintain real-time per-pharmacy stock data. Confirm with pharmacies directly.
Wegovy
semaglutide · Novo Nordisk
Once-weekly semaglutide injection FDA-approved for chronic weight management in adults and adolescents.
Wegovy in Nashville →
Ozempic
semaglutide · Novo Nordisk
Once-weekly semaglutide injection FDA-approved for adults with type 2 diabetes.
Ozempic in Nashville →
Mounjaro
tirzepatide · Eli Lilly
Once-weekly tirzepatide injection FDA-approved for adults with type 2 diabetes.
Mounjaro in Nashville →
Zepbound
tirzepatide · Eli Lilly
Once-weekly tirzepatide injection FDA-approved for chronic weight management and obstructive sleep apnea.
Zepbound in Nashville →
Nashville is a south-region city with a population of 690,000 (2,050,000 in the broader metropolitan area). Tennessee has not expanded Medicaid under the Affordable Care Act, which limits low-income adults' access to GLP-1 coverage; many uninsured residents rely on manufacturer savings programs or compounded options instead.
Statewide, notable health systems include Vanderbilt Health, Methodist Le Bonheur Healthcare.
Tennessee's Medicaid program is TennCare. Coverage rules for GLP-1 medications vary by drug and indication; see our pricing by state map and payer-coverage guides for details.
Cities of similar size with comparable healthcare markets.